On-demand PrEP protects high-risk men against HIV
December 1, 2015|Infectious Disease Practitioner
Author and Disclosure Information
FROM THE NEW ENGLAND JOURNAL OF MEDICINE
“The science has spoken. There can now be no excuse for inaction,” they said.
This study was funded in part by the French National Agency of Research on AIDS and Viral Hepatitis (ANRS). Dr. Molina reports grant support from the ANRS during the conduct of the study, grant support and personal fees from Merck and Gilead, and personal fees from Bristol-Myers Squibb, ViiV, and Janssen outside the submitted work. Dr. Fauci and Dr. Marston reported having no disclosures. Detailed disclosure statements for all authors are available with the full text of the article at NEJM.com.
